2-Chloro-4H-pyrido[1,2-a]pyrimidin-4-one, 95.0%, 2.5g

5-Chloro-3-methylimidazo[1,2-a]pyridine-2-carboxylic acid, 98%, 500mg

2,6-Dinitrobenzonitrile, 98.0%, 10g

3'-Chloro-5'-fluoro-2-piperidinomethyl benzophenone, 97.0%, 1g

tert-Butylsulfonamide, 97.00%, 5g

2-[(4-chlorobenzoyl)amino]-1,3-thiazole-4-carboxylic acid, 95.0%, 500mg

Sample vials, 20 ml, 100 Piece(s)

5-Methoxyquinazoline-2,4(1H,3H)-dione, 95.0%, 1g

2-Cyclopenten-1-one, 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, 95.0%, 250mg

2-(6-Chloro-3-oxo-3,4-dihydro-2h-1,4-benzothiazin-2-yl)acetic acid, 97%, 250mg

1-ISOPROPYL-1H-PYRAZOL-3-OL, 95.0%, 100mg

2-Naphthylacetonitrile>98.0%(GC)5g

Phenylacetylenecarboxylic acid, min. 98%, for synthesis, 5 g, plastic packaging.